Michael Fuller, MD

  • 20 Citations
  • 2 h-Index
19992015

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michael Fuller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Research Output

  • 20 Citations
  • 2 h-Index
  • 2 Article

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder

De La Garza, R., Bubar, M. J., Carbone, C. L., Moeller, F. G., Newton, T. F., Anastasio, N. C., Harper, T. A., Ware, D. L., Fuller, M. A., Holstein, G. J., Jayroe, J. B., Bandak, S. I., Reiman, K. Z., Neale, A. C., Pickford, L. B. & Cunningham, K. A., Jun 3 2015, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 59, p. 40-48 9 p.

Research output: Contribution to journalArticle

  • 8 Scopus citations

    Malignant catatonia-induced respiratory failure with response to ECT

    Boyarsky, B. K., Fuller, M. & Early, T., Dec 1 1999, In : Journal of ECT. 15, 3, p. 232-236 5 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations